Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A full bibliographic citation for an older study was added to the Publications section, and the revision tag Revision: v3.5.4 was included. The erratum note associated with that citation was removed from the Publications/related topics list.
    Difference
    0.2%
    Check dated 2026-05-17T10:08:00.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page's related topics metadata was updated to include 'Ovarian cancer' and 'MedlinePlus Genetics'. This change broadens how the study is indexed for ovarian cancer-related searches without altering the study content.
    Difference
    0.1%
    Check dated 2026-05-03T00:39:15.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A revision/version label on the page was updated from the prior release, indicating a minor ClinicalTrials.gov site change. Additionally, some “related topics” entries in the auxiliary information area (e.g., MedlinePlus Genetics) were removed, without affecting the study details.
    Difference
    0.2%
    Check dated 2026-04-25T17:45:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    - Updated bibliographic reference: revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:12:22.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.0%
    Check dated 2026-03-20T19:55:49.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added the Ovarian cancer topic and a MedlinePlus Genetics related topic, and updated the revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T18:31:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.